Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-40,638
Closed -$2.84M 44
2023
Q2
$2.84M Buy
40,638
+15,695
+63% +$1.05M 0.14% 190
2023
Q1
$1.61M Sell
24,943
-96,428
-79% -$6.6M 0.06% 342
2022
Q4
$8.73M Sell
121,371
-33,159
-21% -$2.22M 0.32% 73
2022
Q3
$8.69M Buy
+154,530
New +$9.09M 0.31% 57
2022
Q2
Sell
-42,056
Closed -$2.71M 1604
2022
Q1
$2.71M Buy
42,056
+27,719
+193% +$1.74M 0.1% 209
2021
Q4
$837K Sell
14,337
-103,348
-88% -$5.79M 0.03% 472
2021
Q3
$6.13M Buy
+117,685
New +$6.43M 0.22% 122
2021
Q2
Sell
-202,333
Closed -$10.4M 1462
2021
Q1
$10.4M Buy
202,333
+7,733
+4% +$371K 0.32% 81
2020
Q4
$8.65M Sell
194,600
-6,400
-3% -$262K 0.29% 89
2020
Q3
$7.31M Buy
+201,000
New +$7.32M 0.97% 24

Other funds holding AFL

Ergoteles's AFL Position: Q3 2023 in Review

Ergoteles sold out of Aflac (AFL) in Q3 2023, closing a stake of 40,638 shares — an estimated $2.84M sold.

Ergoteles first reported a position in AFL in Q3 2020 and held it in 10 quarters. The position peaked at $10.4M in Q1 2021. 1,309 funds tracked by Wall St. Rank hold AFL as of Q3 2023.

  • Ergoteles reported no remaining Aflac position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 40,638 Aflac shares in Q3 2023, an estimated $2.84M.
  • Ergoteles first reported a position in Aflac in Q3 2020 and held it in 10 quarters.
  • Ergoteles's Aflac position peaked at $10.4M in Q1 2021.
  • 1,309 funds tracked by Wall St. Rank held Aflac as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.